{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T10:04:40Z","timestamp":1648980280548},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T00:00:00Z","timestamp":1422316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sleep Breath"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s11325-014-1112-8","type":"journal-article","created":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T09:25:25Z","timestamp":1422264325000},"page":"1043-1049","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk of insomnia with non-vitamin K oral anticoagulants: systematic review and meta-analysis"],"prefix":"10.1007","volume":"19","author":[{"given":"Daniel","family":"Caldeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcio","family":"Barra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Teresa","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy","family":"de Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,27]]},"reference":[{"issue":"Suppl 2","key":"1112_CR1","first-page":"S347","volume":"22","author":"S Ancoli-Israel","year":"1999","unstructured":"Ancoli-Israel S, Roth T (1999) Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation survey. I Sleep 22(Suppl 2):S347\u201353","journal-title":"I Sleep"},{"key":"1112_CR2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00005082-200407000-00003","volume":"19","author":"A Brostr\u00f6m","year":"2004","unstructured":"Brostr\u00f6m A, Str\u00f6mberg A, Dahlstr\u00f6m U, Fridlund B (2004) Sleep difficulties, daytime sleepiness, and health-related quality of life in patients with chronic heart failure. J Cardiovasc Nurs 19:234\u201342","journal-title":"J Cardiovasc Nurs"},{"key":"1112_CR3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/ageing\/32.2.154","volume":"32","author":"JE Byles","year":"2003","unstructured":"Byles JE, Mishra GD, Harris MA, Nair K (2003) The problems of sleep for older women: changes in health outcomes. Age Ageing 32:154\u201363","journal-title":"Age Ageing"},{"key":"1112_CR4","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/j.thromres.2012.06.009","volume":"130","author":"M Sakon","year":"2012","unstructured":"Sakon M, Nakamura M (2012) Darexaban (YM150) prevents venous thromboembolism in Japanese patients undergoing major abdominal surgery: phase III randomized, mechanical prophylaxis-controlled, open-label study. Thromb Res 130:e52\u20139","journal-title":"Thromb Res"},{"key":"1112_CR5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000224861","volume":"83","author":"L Cindolo","year":"2009","unstructured":"Cindolo L, Salzano L, Mirone V, Imbimbo C, Longo N, Kakkos SK, Reddy DJ (2009) Thromboprophylaxis in radical retropubic prostatectomy: efficacy and patient compliance of a dual modality. Urol Int 83:12\u20138","journal-title":"Urol Int"},{"key":"1112_CR6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ije\/dym087","volume":"36","author":"J Pildal","year":"2007","unstructured":"Pildal J, Hr\u00f3bjartsson A, J\u00f8rgensen KJ, Hilden J, Altman DG, G\u00f8tzsche PC (2007) Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol 36:847\u201357","journal-title":"Int J Epidemiol"},{"key":"1112_CR7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","volume":"336","author":"L Wood","year":"2008","unstructured":"Wood L, Egger M, Gluud LL, Schulz KF, J\u00fcni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA (2008) Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 336:601\u20135","journal-title":"BMJ"},{"key":"1112_CR8","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700","journal-title":"BMJ"},{"key":"1112_CR9","unstructured":"Higgins JPT, Altman DG, Sterne JAC (2011) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. http:\/\/www.cochrane-handbook.org. Acessed in December 2013"},{"key":"1112_CR10","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/sim.1188","volume":"21","author":"JJ Deeks","year":"2002","unstructured":"Deeks JJ (2002) Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat Med 21:1575\u2013600","journal-title":"Stat Med"},{"key":"1112_CR11","doi-asserted-by":"crossref","unstructured":"Deeks JJ, Altman DG, Bradburn MJ (2001) Statistical methods for examining heterogeneity and combining results from several studies in metaanalysis. In Egger M, Davey Smith G, Altman DG, editors. Systematic reviews in health care: meta-analysis in context, 2nd ed. London: BMJ Publication Group; p. 313\u2013335","DOI":"10.1002\/9780470693926.ch16"},{"key":"1112_CR12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u201334","journal-title":"BMJ"},{"key":"1112_CR13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","volume":"295","author":"JL Peters","year":"2006","unstructured":"Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295:676\u201380","journal-title":"JAMA"},{"key":"1112_CR14","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1056\/NEJMoa0810773","volume":"361","author":"MR Lassen","year":"2009","unstructured":"Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Portman RJ (2009) Apixaban or enoxaparin for thromboprophylaxis after knee replacement. N Engl J Med 361:594\u2013604","journal-title":"N Engl J Med"},{"key":"1112_CR15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1105819","volume":"365","author":"JH Alexander","year":"2011","unstructured":"Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S et al (2011) Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med 365:699\u2013708","journal-title":"N Engl J Med"},{"key":"1112_CR16","doi-asserted-by":"crossref","unstructured":"Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Prins MH, Hettiarachchi R, Hantel S, Schnee J, B\u00fcller HR; RE-NOVATE Study Group (2007) Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet. 15;370:949\u201356","DOI":"10.1016\/S0140-6736(07)61445-7"},{"key":"1112_CR17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1160\/TH10-10-0679","volume":"105","author":"BI Eriksson","year":"2011","unstructured":"Eriksson BI, Dahl OE, Huo MH, Kurth AA, Hantel S, Hermansson K, Schnee JM, Friedman RJ, Study Group RE-NOVATEII (2011) Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial. Thromb Haemost 105:721\u20139","journal-title":"Thromb Haemost"},{"key":"1112_CR18","doi-asserted-by":"crossref","unstructured":"Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W; RECORD1 Study Group (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med. 26;358:2765\u201375.","DOI":"10.1056\/NEJMoa0800374"},{"key":"1112_CR19","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1056\/NEJMoa076016","volume":"358","author":"MR Lassen","year":"2008","unstructured":"Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, Misselwitz F, Turpie AG, RECORD3 Investigators (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 358:2776\u201386","journal-title":"N Engl J Med"},{"key":"1112_CR20","unstructured":"Sterne JAC, Egger M, Moher D (2011) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration. http:\/\/www.cochrane-handbook.org. Acessed in December 2013"},{"key":"1112_CR21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0163-7258(90)90092-G","volume":"46","author":"J McAinsh","year":"1990","unstructured":"McAinsh J, Cruickshank JM (1990) Beta-blockers and central nervous system side effects. Pharmacol Ther 46:163\u201397","journal-title":"Pharmacol Ther"},{"key":"1112_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2133\/dmpk.DMPK-12-RG-004","volume":"28","author":"CH Chang","year":"2013","unstructured":"Chang CH, Yang YH, Lin SJ, Su JJ, Cheng CL, Lin LJ (2013) Risk of insomnia attributable to \u03b2-blockers in elderly patients with newly diagnosed hypertension. Drug Metab Pharmacokinet 28:53\u20138","journal-title":"Drug Metab Pharmacokinet"}],"container-title":["Sleep and Breathing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-014-1112-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11325-014-1112-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-014-1112-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:47:23Z","timestamp":1559396843000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11325-014-1112-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,27]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1112"],"URL":"https:\/\/doi.org\/10.1007\/s11325-014-1112-8","relation":{},"ISSN":["1520-9512","1522-1709"],"issn-type":[{"value":"1520-9512","type":"print"},{"value":"1522-1709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,27]]}}}